Emily Lin, PhD, is a proven assay development expert currently serving as a Principal Scientist at Roche Molecular Systems, where they lead technical projects related to CoV-19 testing from concept to market. Previously, Emily worked as a Senior Scientist at Luminex Corporation, where they successfully integrated PCR systems and received the corporate "Outstanding Employee Award." Earlier in their career, they were a Scientist at Novartis, contributing to the development of an HCV vaccine candidate published in notable journals and presented at international conferences. Emily earned their PhD in Microbiology & Immunology from National Cheng Kung University and completed a postdoc at Indiana University School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices